+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

From
Sinusitis - Pipeline Insight, 2025 - Product Thumbnail Image

Sinusitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
Sarcoidosis - Pipeline Insight, 2025 - Product Thumbnail Image

Sarcoidosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 75 Pages
  • Global
From
Bronchopulmonary Dysplasia - Pipeline Insight, 2025 - Product Thumbnail Image

Bronchopulmonary Dysplasia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Bronchiectasis - Pipeline Insight, 2025 - Product Thumbnail Image

Bronchiectasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 70 Pages
  • Global
From
Bacterial Pneumonia - Pipeline Insight, 2025 - Product Thumbnail Image

Bacterial Pneumonia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Bronchitis - Pipeline Insight, 2025 - Product Thumbnail Image

Bronchitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Community-acquired Pneumonia (CAP) - Pipeline Insight, 2025 - Product Thumbnail Image

Community-acquired Pneumonia (CAP) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Middle East Respiratory Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Middle East Respiratory Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 65 Pages
  • Middle East
From
Sleep Apnoea Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Sleep Apnoea Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Chronic Refractory Cough - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Refractory Cough - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Neonatal Respiratory Distress Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Neonatal Respiratory Distress Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Pulmonary Alveolar Proteinosis - Pipeline Insight, 2025 - Product Thumbnail Image

Pulmonary Alveolar Proteinosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
From
Alpha-1 Antitrypsin Deficiency- Pipeline Insight, 2025 - Product Thumbnail Image

Alpha-1 Antitrypsin Deficiency- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 220 Pages
  • Global
From
Pertussis- Pipeline Insight, 2025 - Product Thumbnail Image

Pertussis- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Pneumococcal Pneumonia - Pipeline Insight, 2025 - Product Thumbnail Image

Pneumococcal Pneumonia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Pseudomonas Aeruginosa-Induced Lung Injury - Pipeline Insight, 2025 - Product Thumbnail Image

Pseudomonas Aeruginosa-Induced Lung Injury - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more